Photo from wikipedia
Atopic dermatitis is a chronic, relapsing skin inflammation disease that generally affects 20% of children and 1–3% of adults. It is characterized by pruritus, inflammatory skin lesions, and skin barrier… Click to show full abstract
Atopic dermatitis is a chronic, relapsing skin inflammation disease that generally affects 20% of children and 1–3% of adults. It is characterized by pruritus, inflammatory skin lesions, and skin barrier defect. The pillar treatment is topical therapies that have shown great adherence and incredible results in alleviating symptoms of atopic dermatitis. Topical corticosteroids and calcineurin inhibitors have shown improvement in the symptoms of atopic dermatitis but have certain side effects. There is need to develop new therapies or novel drug delivery approaches which can overcome drawbacks of the conventional formulation and increase the therapeutic efficacy.
Journal Title: Journal of Cosmetic Dermatology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!